We draw attention to a new factor complicating presentation and diagnosis of pigmented lesions1: unlicensed use of melanotropic peptides offered online as Melanotan I and II. Two patients presented to our dermatology clinic with rapidly changing moles and a conspicuous tan, despite their sun reactive skin type I/II (sunburns easily, suntans poorly). They were both sunbed users. One, a woman of 42, reported two moles on her …
No takes yet. Share an insight, caveat, or question.
Langan et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: